Death after re-exposure to propofol in a 3-year-old child: A case report

Paediatric Anaesthesia

Volumn 14, Issue 3, 2004, Pages 265-270

  Holzki, Josef ^a,b   Aring, Christoph ^a   Gillor, Alex ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b Department of Paediatric Anaesthesia ^*  (Germany)

Author keywords

Brady dysrhythmias; Children; Long term sedation; Propofol toxicity

Indexed keywords

FENTANYL; MIDAZOLAM; PROPOFOL;

ARTICLE; ARTIFICIAL HEART PACEMAKER; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; BLOOD OXYGENATION; BOLUS INJECTION; BRADYCARDIA; BRONCHOSPASM; CASE REPORT; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIFFERENTIAL DIAGNOSIS; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG REEXPOSURE; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART OUTPUT; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERCAPNIA; LONG TERM CARE; METABOLIC ACIDOSIS; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; RESPIRATORY ACIDOSIS; RHABDOMYOLYSIS; SEDATION; SYNDROME DELINEATION; THORAX RADIOGRAPHY;

ACIDOSIS; CHILD, PRESCHOOL; FATAL OUTCOME; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; OVERDOSE; PROPOFOL; SYNDROME;

EID: 1642284413     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.01179.x     Document Type: Article

References (11)

1. Pessenbacher K, Gutmann A, Eggenreich U et al. Two propofol formulations are equivalent in small children aged 1 month to 3 years. Acta Anaesthesiol Scand 2002; 46: 257-263.
2. Reinhold P, Kraus G, Schlüter E. Propofol zur Narkose und Kurzzeitsedierung. Plädoyer für die Anwendung auch bei Kindern unter drei Jahren. Anaesthesist 1998; 47: 229-237.
3. Parke TJ, Stevens JE, Rice ASC et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992; 305: 613-616.
4. Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth 1998; 8: 491-499.
5. Kanto J, Gepts E. Pharmacokinetic implications for the clinical use of propofol. Clin Pharmacokinet 1989; 17: 308-326.
6. Cremer OL, Moons KGM, Bauman EAC et al. Long term propofol infusion and cardiac failure in adult head injured patients. Lancet 2001; 357: 117-118.
7. Martin PH, Murthy BVS, Petros AJ. Metabolic, biochemical and haemodynamic effects of infusion of propofol for long-term sedation of children undergoing intensive care. Br J Anaesth 1997; 79: 276-279.
8. Hatch D. Propofol in paediatric intensive care. Editorial. Br J Anaesth 1997; 79: 274-275.
9. Cray S. Correspondence. Br J Anaesth 1999; 82: 473.
10. Schuff A, Fries J, Grass H. 'Learning by doing'. Zur Arzneimittelsicherheit in der Pädiatrie an einem Fallbeispiel mit Propofol. Abstract. Rechtsmedizin 2001; 11: 186.
11. Wolf A, Weir P, Segar Ph et al. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 2002; 357: 606-607.